Asuragen Publications

Filipovic-Sadic S, Sah S, Chen L, Krosting J, Sekinger E, Zhang W, Hagerman PJ, Stenzel TT, Hadd AG, Latham GJ, Tassone F.A Novel FMR1 PCR Method for the Routine Detection of Low Abundance Expanded Alleles and Full Mutations in Fragile X Syndrome. Clin Chem. 2010 Mar;56(3):399-408

Kuokkanen S, Chen B, Ojalvo L, Benard L, Santoro N, Pollard JW.Genomic Profiling of MicroRNAs and Messenger RNAs Reveals Hormonal Regulation in MicroRNA Expression in Human Endometrium. Biol Reprod. 2010 Apr;82(4):791-801

Weingartl HM, Berhane Y, Hisanaga T, Neufeld J, Kehler H, Emburry-Hyatt C, Hooper-McGreevy K, Kasloff S, Dalman B, Bystrom J, Alexandersen S, Li Y, Pasick J. Genetic and Pathobiologic Characterization of Pandemic H1N1 2009 Influenza Viruses from a Naturally Infected Swine Herd. J Virol. 2010 Mar; 84 (5):2245-56

Madej RM, Davis J, Holden MJ, Kwang S, Labourier E, Schneider GJ. International standards and reference materials for quantitative molecular infectious disease testing.. J Mol Diagn. 2010 Mar;12 (2):133-43

Krupa A, Jenkins R, Luo DD, Lewis A, Phillips A, Fraser D.Loss of MicroRNA-192 promotes fibrogenesis in diabetic nephropathy.. J Am Soc Nephrol. 2010 Mar; 21 (3):438-47

Chen Y, Tassone F, Berman RF, Hagerman PJ, Hagerman RJ, Willemsen R, Pessah IN.Murine hippocampal neurons expressing Fmr1 gene premutations show early developmental deficits and late degeneration. Hum Mol Genet. 2010 Jan;19 (1):196-208

Barbosa-Morais NL, Dunning MJ, Samarajiwa SA, Darot JF, Ritchie ME, Lynch AG, Tavaré S.A re-annotation pipeline for Illumina BeadArrays: improving the interpretation of gene expression data.. Nucleic Acids Res. 2010 Jan;38(3):e17

Beaudenon S and Huibregtse JM. HPV E6, E6AP and cervical cancer. BMC Biochem 2008; 9 Suppl 1: S4.

Szafranska AE, Davison TS, Shingara J, Doleshal M, Riggenbach JA, Morrison CD, Jewell S, and Labourier E. Accurate molecular characterization of formalin-fixed, paraffin-embedded tissues by microRNA expression profiling. Mol Diagn 2008; 10(5): 415-23.

Szafranska AE, Doleshal M, Edmunds HS, Gordon S, Luttges J, Munding JB, Barth RJ Jr, Gutmann EJ, Suriawinata AA, Pipas JM, Tannapfel A, Korc M, Hahn SA, Labourier E, and Tsongalis GJ.Analysis of MicroRNAs in Pancreatic Fine-Needle Aspirates Can Classify Benign and Malignant Tissues. Clin. Chem. 2008; 54:1716-1724.

JP Cogswell, J Ward, IA Taylor, M Waters, Y Shi, B Cannon, K Kelnar, J Kemppainen, D Brown, C Chen, RK Prinjha, JC Richardson, AM Saunders, AD Roses, and CA Richards. Identification of miRNA changes in Alzheimer's disease brain and CSF yields putative biomarkers and insights into disease pathways. J Alzheimers Dis. May 2008; 14(1): 27-41.

Peltier HJ, Latham GJ. Normalization of microRNA expression levels in quantitative RT-PCR assays: identification of suitable reference RNA targets in normal and cancerous human solid tissues. RNA. 2008 May;14(5):844-52. Epub 2008 Mar 28.

Doleshal M, Magotra AA, Choudhury B, Cannon BD, Labourier E, Szafranska AE. Evaluation and validation of total RNA extraction methods for MicroRNA expression analyses in formalin-fixed, paraffin-embedded tissues. J Mol Diagn. 2008 May;10(3):203-11. Epub 2008 Apr 10.

Pappas TC, Bader AG, Andruss BF, Brown D, Ford LP. Applying small RNA molecules to the directed treatment of human diseases: realizing the potential. Expert Opin Ther Targets 2008, 12:115-127.

Johnson CD, Esquela-Kerscher A, Stefani G, Byrom M, Kelnar K, Ovcharenko D, Wilson M, Wang X, Shelton J, Shingara J, et al. The let-7 MicroRNA Represses Cell Proliferation Pathways in Human Cells. Cancer Res 2007, 67:7713-7722.

Ovcharenko D, Kelnar K, Johnson C, Leng N, Brown D. Genome-Scale MicroRNA and Small Interfering RNA Screens Identify Small RNA Modulators of TRAIL-Induced Apoptosis Pathway. Cancer Res 2007, 67:10782-10788.

Szafranska AE, Davison TS, John J, Cannon T, Sipos B, Maghnouj A, Labourier E, Hahn SA. MicroRNA expression alterations are linked to tumorigenesis and non-neoplastic processes in pancreatic ductal adenocarcinoma. Oncogene 2007, 26:4442-4452.

Brown JT, Lahey C, Laosinchai-Wolf W, Hadd AG. Polymorphisms in the glucocerebrosidase gene and pseudogene urge caution in clinical analysis of Gaucher disease allele c.1448T>C (L444P). BMC Med Genet 2006, 7:69.

Cummins JM, He Y, Leary RJ, Pagliarini R, Diaz LA, Jr., Sjoblom T, Barad O, Bentwich Z, Szafranska AE, Labourier E, et al. The colorectal microRNAome. Proc Natl Acad Sci U S A 2006, 103:3687-3692.

Davison TS, Johnson CD, Andruss BF. Analyzing Micro-RNA Expression Using Microarrays. Methods Enzymol 2006, 411:14-34.

Madabusi LV, Latham GJ, Andruss BF. RNA extraction for arrays. Methods Enzymol 2006, 411:1-14.

Shi L, Reid LH, Jones WD, Shippy R, Warrington JA, Baker SC, Collins PJ, de Longueville F, Kawasaki ES, Lee KY, et al.: The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat Biotechnol 2006, 24:1151-1161.

Shippy R, Fulmer-Smentek S, Jensen RV, Jones WD, Wolber PK, Johnson CD, Pine PS, Boysen C, Guo X, Chudin E, et al. Using RNA sample titrations to assess microarray platform performance and normalization techniques. Nat Biotechnol. 2006, 24:1123-1131.

Cheng AM, Byrom MW, Shelton J, Ford LP: Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis. Nucleic Acids Res 2005, 33:1290-1297.

Hadd AG, Brown JT, Andruss BF, Ye F, WalkerPeach CR. Adoption of array technologies into the clinical laboratory. Expert Rev Mol Diagn 2005, 5:409-420.

Johnson SM, Grosshans H, Shingara J, Byrom M, Jarvis R, Cheng A, Labourier E, Reinert KL, Brown D, Slack FJ. RAS Is Regulated by the let-7 MicroRNA Family. Cell 2005, 120:635-647.

Ovcharenko D, Jarvis R, Hunicke-Smith S, Kelnar K, Brown D. High-throughput RNAi screening in vitro: From cell lines to primary cells. RNA2005, 11:985-993.

Shingara J, Keiger K, Shelton J, Laosinchai-Wolf W, Powers P, Conrad R, Brown D, Labourier E. An optimized isolation and labeling platform for accurate microRNA expression profiling. RNA 2005, 11:1461-1470.

Hadd AG, Laosinchai-Wolf W, Novak CR, Badgett MR, Isgur LA, Goldrick M, Walkerpeach CR. Microsphere bead arrays and sequence validation of 5/7/9T genotypes for multiplex screening of cystic fibrosis polymorphisms. J Mol Diagn2004, 6:348-355.

Walkerpeach CR, Pasloske BL. DNA bacteriophage as controls for clinical viral testing. Clin Chem 2004, 50:1970-1971.

Brown D, Pasloske BL. Ribonuclease-resistant RNA controls and standards. Methods Enzymol 2001, 341:648-654.

WalkerPeach CR, Winkler M, DuBois DB, Pasloske BL. Ribonuclease-resistant RNA controls (Armored RNA) for reverse transcription-PCR, branched DNA, and genotyping assays for hepatitis C virus. Clin Chem 1999, 45:2079-2085.

Pasloske BL, Walkerpeach CR, Obermoeller RD, Winkler M, DuBois DB: Armored RNA technology for production of ribonuclease-resistant viral RNA controls and standards. J Clin Microbiol 1998, 36:3590-3594.

Select your region

Map of the world

Select your region below to learn more about Asuragen’s technology and scientific expertise as well as information about products available in your region.